[DailyPharm] “In-Depth Review of Pharmacoeconomic Evaluation Exemptions and RSA Case Studies”… Lee & Ko’s Inaugural Market Access Academy Draws Strong Turnout

On September 3, 2026, DailyPharm reported that Lee & Ko launched the “Inaugural Lee & Ko MA Academy,” a training program designed to enhance the expertise of pricing and market access (MA) practitioners in the pharmaceutical industry. Starting with its first lecture on September 2, Lee & Ko is offering a six-session course covering key regulatory frameworks and practical issues relating to drug pricing and MA in the pharmaceutical and biotechnology sectors. The opening lecture, titled “A One-Stop Guide to New Drug Listing Regulations,” was delivered by Sungju Kim, a Senior In-House Advisor at Lee & Ko.